Variable | Cefazolin (n = 73) | Ertapenem (n = 67) | P |
---|---|---|---|
Source of infection | |||
Urinary | 62 (85%) | 47 (70%) | 0.09 |
SSI | 3 (4%) | 6 (9%) | 0.5 |
Other | 8 (11%) | 14 (21%) | 0.3 |
Positive blood cultures | 10 (14%) | 8 (12%) | 0.4 |
Septic shock | 2 (3%) | 1 (2%) | 0.6 |
Isolated microorganisms | |||
Enterobacteriaceae | 47 (64%) | 24 (36%) | 0.005 |
ESBL-producing | 10 (21%)a | 2 (8%)b | 0.01 |
P. aeruginosa | 9 (12%) | 9 (14%) | 1 |
XDR | 5 (56%) | 2 (22%) | 0.2 |
Enterococcus spp. | 24 (33%) | 31 (47%) | 0.1 |
E. faecium | 13 (54%) | 8 (26%) | 0.03 |
C. difficile colitis | 1 (1%) | 2 (3%) | 1 |
Candida spp. infection | 7 (9%) | 3 (5%) | 0.1 |
CR Enterobacteriaceae | 0 | 0 |